Jack Ma-backed fund, Temasek invest in genomics business
Add BT as a preferred source
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Hong Kong
A FUND backed by Chinese billionaire Jack Ma and Singapore's state-owned investment firm, Temasek Holdings Pte, made new investments in contract genomics organisation WuXi NextCODE, which is expanding in China as the country pushes into the emerging field of precision medicine.
Yunfeng Capital and Temasek co-led a US$75 million Series B round of financing into the company, WuXi NextCODE said in a statement.
Share with us your feedback on BT's products and services
TRENDING NOW
Japan stocks look set for new highs in 2025 on earnings, reform
Beijing’s calculated silence on the Iran war
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Richard Eu on how core values, customers keep Singapore’s TCM chain Eu Yan Sang relevant
